SACT data reports

There are a range of reports available and we are looking to expand and improve the information available from the SACT dataset.

If you have any queries about the reports available please do contact the team SACT team at sact@phe.gov.uk.

We are launching a SACT newsletter and will use this to inform subscribers of any new reports and updates. Please contact the SACT team if you would like to receive the newsletter.

 

National study of 30-day mortality following SACT treatment

In 2016 Public Health England (PHE) published a study on 30–day mortality after systemic anti-cancer therapy for breast and lung cancer in England for 2014 using SACT data. The study was published in the Lancet Oncology and was produced in collaboration with Cancer Research UK. We also published a companion report that provided trust level analyses of the data.

We are working with our clinical advisors on a follow up to this study that will provide 30-day mortality across a range of cancer types and years. We aim to publish our analyses by late 2018.

 30 day mortality post-systemic anti-cancer therapy (SACT) workbook (2018 release)

As a follow up to this publication, we have developed a workbook documenting 30 day mortality rates post-SACT.  The workbook contains:

  • Annual rates of 30 day mortality post-SACT, 2015 and 2016. 
  • A broader range of cancers than the original publication
  • Crude mortality rates (not risk adjusted)

It is designed as a pilot for a future, routine feed of 30 day mortality rates post-SACT and aims to support clinical practice at NHS trusts.

This work is based on routine data submitted by hospitals to the SACT dataset. Please note that factors such as differences in patient case mix (which we have not adjusted for), random variation, data ascertainment and quality will all impact on the results. These factors mean that we cannot be certain that a high mortality rate reflects an issue with clinical care. The workbook is not a quality indicator and has been designed to support clinical practice.

As a result we have conducted a “trust notification process” rather than a formal “outlier process” for this report. In the notification process, all trusts received the workbook and were encouraged to review their data.  Any results which were above the expected level of variation were highlighted to the appropriate trusts.  Trust comments following the notification process are published in the companion briefing.

Excel 30 day mortality post SACT 2015-16 workbook

pdf FAQs: 30 day mortality post SACT 2015-16 workbook

pdf Companion brief: 30 day mortality post SACT 2015-16 workbook

pdf Evaluation report: 30 day mortality post SACT 2015-16 workbook 

 

Public Health England’s CancerStats portal

The new CancerStats reporting portal gives registered users access to interactive SACT reports.

The portal does not provide identifiable data but it does have detailed local data. To ensure this data is secure it is only available through the NHS N3 network. Users must register on the homepage and have a suitable justification for accessing the data.

The following reports are currently available:

CTYA reports

Captures information on treatment patterns for child, teenage and young adult cancers.

 

The following reports will soon be launched:

SACT data quality and completeness reports

Data Quality and completeness reports will be available on Cancerstats2.

The reports show data submitted by trusts in comparison to the national average. The SACT team are re-creating these reports on CancerStats with increased user functionality.

For data submitted prior to May 2018, please send a request to the SACT helpdesk team.

SACT routine reporting suite

Captures information previously sent to trusts in the "All England" and "Regional" report suites. Shows key patterns and use of SACT across NHSE trusts including detail such as number of patients receiving treatment for each tumour group, number/proportions of regimens reported by treatment intent and tumour group, and information on patient performance status.

We are working to expand the reports available on CancerStats to help providers review and compare their use of SACT and the patients receiving treatment. If you have any suggestions for reports which would be value for the future, please email sact@phe.gov.uk.

 

Other SACT reports

Cumulative SACT data completeness report

The cumulative data completeness report provides an indication of the completeness of SACT data across a 12 month period. This report provides a simple estimate of the quality and completeness of SACT data nationally and by trust and region. In future these data will be captured by the data completeness report on CancerStats. We will continue to make this report publically available once a year for the most recent 12 month period.

The figures in this report hide certain data quality issues and include treatments that are submitted by trusts alongside SACT data that are outside of the scope of the SACT dataset.

Excel Data Completeness Report: April 2017 – March 2018

Chemotherapy, radiotherapy and tumour resection in England

This report introduces new data on the percentage of tumours diagnosed in England in 2013 - 2014 recorded as receiving radiotherapy, chemotherapy or tumour resection. It examines differences by cancer site and stage at diagnosis. The report and accompanying data are available from the main National Cancer Registration and Analysis Service website.

 

Data Resource Profile

Data Resource Profile: The Systemic Anti-Cancer Therapy (SACT) Dataset

This recent publication in the International Journal of Epidemiology gives a detailed insight into the scope and potential of the SACT dataset.  It discusses the dataset structure, data items collected, strengths and weaknesses of the dataset and describes how to access the data.

 

Outlier Management

The SACT teams approach to the handling of outliers mirrors NCRAS Guidance on Handling Outlier Institutions and has been developed from Department of Health and Healthcare Quality Improvement Partnership guidance and experience in dealing with these issues. The approach  recognises that flexibility is required to account for different circumstances and therefore provides a set of principles to be followed rather than a detailed procedure to cover every eventuality.

NCRAS co-ordinating team can advise on planning for the handling of outliers and may be able to assist with the management of the process. To access the guidance please visit the NCRAS website.